
SummaryImmune thrombocytopenia (ITP) refractory to multiple therapies may require a combination of drugs targeting different mechanisms and targets. In this retrospective, multicentre, international study, we report the safety and effectiveness of avatrombopag and fostamatininb in combination administered to 18 patients with multirefractory ITP. Overall, the combination response was achieved in 15 patients (83.3%), with a median time from combination start to best response of 15 days (IQR: 8–35 days). After a median follow‐up of 256 days (IQR: 142.8–319), 5 patients relapsed (26.7%), all during tapering or stopping one drug. Adverse events were described in 6 of 18 patients (33%).
Adult, Male, Pyridines, Morpholines, Aminopyridines, Thiophenes, Oxazines, Humans, Aged, Retrospective Studies, Purpura, Thrombocytopenic, Idiopathic, Combining treatment, TPO‐RA, Middle Aged, SYK inhibitor, Thiazoles, Hydrazines, Pyrimidines, Treatment Outcome, ITP, Pyrazoles, Female, Drug Therapy, Combination
Adult, Male, Pyridines, Morpholines, Aminopyridines, Thiophenes, Oxazines, Humans, Aged, Retrospective Studies, Purpura, Thrombocytopenic, Idiopathic, Combining treatment, TPO‐RA, Middle Aged, SYK inhibitor, Thiazoles, Hydrazines, Pyrimidines, Treatment Outcome, ITP, Pyrazoles, Female, Drug Therapy, Combination
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 10 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
